India's Intas revives plans to go public
This article was originally published in Scrip
Executive Summary
Intas Pharmaceuticals has revived plans for an initial public offering – potentially the first from a well-established Indian formulations company in recent times and one that will also see the India-focused investment firm, ChrysCapital, make a partial exit from the company.